scholarly journals The Role of the Spiritual Meaning System in Coping with Cancer

Religions ◽  
2020 ◽  
Vol 11 (1) ◽  
pp. 49 ◽  
Author(s):  
Anja Visser ◽  
Nicoline Uwland-Sikkema ◽  
Gerben J. Westerhof ◽  
Bert Garssen

Spirituality can support the adjustment process of people with cancer, by forming a meaning system that supports understanding of the cause and implications of the experience and that provides coping strategies. The different ways in which spiritual meaning systems might fulfill these roles were examined among 20 people who were treated for cancer with curative intent. Narrative interviews were held on average 16 months after cancer diagnosis. The interviews were analyzed in a two-stage process, based on a holistic content approach. The first stage led to the identification of various roles and outcomes of the meaning system. The second stage involved a comparison of these roles and outcomes between previously defined types of meaning systems. The roles identified were discrepancy, legitimation and continuation. Legitimation was associated with the outcome of integration, whereas continuation was associated with an outcome of a positive outlook toward the future. Several differences were found between types of meaning systems, regarding the extent to which and ways in which these roles and outcomes occurred. This study underscores recommendations that healthcare professionals should be aware of the different ways in which the patient’s previous beliefs and experiences influence their current adaptation to serious life events.

Religions ◽  
2021 ◽  
Vol 12 (4) ◽  
pp. 284
Author(s):  
Wojciech Rodzeń ◽  
Małgorzata Maria Kulik ◽  
Agnieszka Malinowska ◽  
Zdzisław Kroplewski ◽  
Małgorzata Szcześniak

Does the way we think or feel about ourselves have an impact on our anger-based reactions? Is the direction and strength of this relationship direct, or affected by other factors as well? Given that there is a lack of research on the loss of self-dignity and anger, the first aim of the present study consisted in examining whether or not there is a connection between both variables, with particular emphasis on early adulthood. The second purpose was to explore the moderating role of religiosity on the relationship between loss of self-dignity and anger. Methods: Data were gathered from 462 participants aged 18 to 35. The main methods applied were the Questionnaire of Sense of Self-Dignity, Buss–Perry Aggression Questionnaire, and Religious Meaning System Questionnaire. The results show a statistically significant positive correlation between loss of self-dignity and anger, a negative correlation between religiosity and anger, and no significant association between the loss of self-dignity and religiosity. However, all other dimensions of the sense of self-dignity correlated positively with religiosity. Our findings also confirm that the level of anger resulting from the loss of self-dignity is significantly lower as the level of religiosity increases. Such outcomes seem to support the conception that religiosity may act as a protective factor between the risk (loss of self-dignity) and the outcome factor (anger).


2009 ◽  
pp. 59-74
Author(s):  
R. Cassibba ◽  
E. Costantino ◽  
S. Papagna ◽  
R. Montanaro ◽  
V. Mattioli

- The diagnosis of cancer troubles people and their identity; it is a threat for their survival. To cope with cancer, people have to collect all their psychological and relational resources. The behavioral system of attachment is activated when people are in danger and it makes them looking for significant others who can be a "secure base" for them. This study investigates the role of specific adult attachment relationships, such as the bond with God and with the partner, on coping with cancer, hypothesizing that patients with a secure attachment with God or with the partner cope better and perceive less stress, respect to patients with an insecure attachment. The results show that the intensity of religious beliefs and security of attachment with God and with the partner are associated to some specific coping strategies to cancer. In particular, insecurity of attachment to God and a specific aspect of insecurity of attachment to the partner (fear of loss) are connected to a higher level of anxiety and a lower level of fighting spirit in coping with cancer. Only attachment to God is associated to a lower level of perceived stress.


2018 ◽  
Vol 99 (1) ◽  
pp. 10-13 ◽  
Author(s):  
Nicole L Stout ◽  
Julie K Silver ◽  
Catherine M Alfano ◽  
Kirsten K Ness ◽  
Laura S Gilchrist

2019 ◽  
Vol 37 (4_suppl) ◽  
pp. 376-376
Author(s):  
Rachel M Lee ◽  
Danielle K DePalo ◽  
Alexandra G Lopez-Aguiar ◽  
Mohammad Yahya Zaidi ◽  
Flavio G. Rocha ◽  
...  

376 Background: The prognostic value of pathologic variables is not consistent for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). We previously demonstrated a limited prognostic role of lymph node (LN) positivity in small bowel NETs (SBNET) compared to pancreatic NETs (panNET). Although minority race is often associated with worse cancer outcomes, the interaction of race with pathologic and oncologic outcomes of pts with GEP-NETS is not known. Methods: Pts with GEP-NETs who underwent curative intent resection at eight institutions of the US NET Study Group from 2000-16 were included. Given few pts of other races, only Black and White race pts were analyzed. Results: Of 2,182 pts, 1,143 met inclusion criteria. Median age was 58 yrs, median follow up was 3 yrs, 48% were male, 14% (n = 157) were Black, and 86% (n = 986) were White. Black pts were more likely uninsured (7 vs 2%, p = 0.005), had symptomatic bleeding (13 vs 7%, p = 0.006), required emergency surgery (7 vs 3%, p = 0.003), and had LN positive disease (47 vs 36%, p = 0.016). Despite this, Black pts had improved 5 yr recurrence free survival (RFS) compared to White pts (90 vs 80%, p = 0.008). The quality of care received was comparable between both groups, demonstrated by similar LN yield at surgery, neg margin resection rate, post-op complications, and need for reoperation or readmission (all p > 0.05). Black pts were more likely to have SBNET (22 vs 13%) and less likely to have panNET (43 vs 68%) compared to White pts (p < 0.001). Consistent with prior data, pts with LN pos panNET had decreased 5yr RFS (67 vs 83%, p = 0.001); however, for SBNET, LN involvement was not prognostic (77 vs 96%, p = 0.08). The prognostic value of LN pos disease was similar between Black and White pts in both SBNET (p = 0.34) and panNET (p = 0.95). Conclusions: Black pts with GEP-NET present with more advanced disease, including higher LN positivity. Despite this, Black pts have improved RFS compared to White pts. Although there may be delays in seeking or reaching care, Black pts received similar quality of care compared to White pts. The improved RFS seen in Black pts may be attributed to the epidemiologic differences in the site of presentation of GEP-NETs and variable prognostic value of LN pos disease.


2016 ◽  
Vol 9 (2_suppl) ◽  
pp. 24-29 ◽  
Author(s):  
Charlotte Gunner ◽  
Aziz Gulamhusein ◽  
Derek J Rosario

Introduction: Approximately 50% of men diagnosed with prostate cancer will be exposed to androgen deprivation therapy (ADT) at some stage. The role of ADT in the management of metastatic disease has long been recognised, and its place in the management of localised and locally advanced disease has become clearer in the past few years. Nevertheless, concerns remain that some men might not benefit from ADT in earlier-stage disease. The purpose of the current article is to provide a brief narrative review of the role of ADT as part of a strategy of treatment with curative intent, concentrating mainly on key recent developments in the area. Methods: Narrative literature review of key publications in the English language relating to ADT in the management of localised and locally advanced prostate cancer. Results: In locally advanced and high-risk localised prostate cancer, the use of ADT in combination with radiotherapy improves disease-specific and overall survival. There is no evidence to support the use of ADT in the treatment of low-risk localised prostate cancer. There appears to be an increased risk of cardiovascular morbidity and mortality associated with luteinizing hormone-releasing hormone agonists, particularly in men with pre-existing cardiovascular disease, but the relevance of this in the adjuvant/neoadjuvant setting is currently unclear. Conclusions: Future studies should focus on identification of men who are at risk from cardiovascular complications associated with ADT and on the comparison of radiotherapy with ADT versus surgery in the management of localised and locally advanced prostate cancer, particularly with regards to men with pre-existing comorbidities.


Sign in / Sign up

Export Citation Format

Share Document